ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in June 2022. Updated June 30.
A roundup of FDA’s actions in June 2022.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in June 2022. Updated June 30.
A roundup of FDA’s actions in June 2022.